Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084291 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Takuya Miyano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science Department II, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa, Tokyo 140-8710, Japan. Hauptthemen laut MEDLINE: Schizophrenia, Inflammation, Biomarkers, Psychotic Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daiichi-Sankyo (Japan), Daiichi Sankyo Co., Ltd..
Abstract (Originalsprache)
Schizophrenia is a complex and heterogenous psychiatric disorder. This study aimed to demonstrate the potential of circulating microRNAs (miRNAs) as a clinical biomarker to stratify schizophrenia patients and to enhance understandings of their heterogenous pathophysiology. We measured levels of 179 miRNA and 378 proteins in plasma samples of schizophrenia patients experiencing acute psychosis and obtained their Positive and Negative Syndrome Scale (PANSS) scores. The plasma miRNA profile revealed three subgroups of schizophrenia patients, where one subgroup tended to have higher scores of all the PANSS subscales compared to the other subgroups. The subgroup with high PANSS scores had four distinctively downregulated miRNAs, which enriched ‘Immune Response’ according to miRNA set enrichment analysis and were reported to negatively regulate IL-1β, IL-6, and TNFα. The same subgroup had 22 distinctively upregulated proteins, which enriched ‘Cytokine-cytokine receptor interaction’ according to protein set enrichment analysis, and all the mapped proteins were pro-inflammatory cytokines. Hence, the subgroup is inferred to have comparatively high inflammation within schizophrenia. In conclusion, miRNAs are a potential biomarker that reflects both disease symptoms and molecular pathophysiology, and identify a patient subgroup with high inflammation. These findings provide insights for the precision medicinal strategies for anti-inflammatory treatments in the high-inflammation subgroup of schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Science Department II, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa, Tokyo 140-8710, Japan.
- Clinical Research Department, Sirtsei Pharmaceuticals, Inc., 3000 RDU Center Drive, Suite 130, Morrisville, NC 27560, USA.
- Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., 1-16-13 Kitakasai, Edogawa, Tokyo 134-8630, Japan.
ORCID-Profile: Takuya Miyano, Tsuyoshi Mikkaichi
Förderung
- Daiichi-Sankyo (Japan)
- Daiichi Sankyo Co., Ltd.
Zitieren
APA
Miyano, T., Mikkaichi, T., Nakamura, K., Yoshigae, Y., Abernathy, K., Ogura, Y., & Kiyosawa, N. (2024). Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084291
Vancouver
Miyano T, Mikkaichi T, Nakamura K, Yoshigae Y, Abernathy K, Ogura Y, et al. Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084291
BibTeX
@article{Miyano2024,
author = {Miyano, Takuya and Mikkaichi, Tsuyoshi and Nakamura, Kouichi and Yoshigae, Yasushi and Abernathy, Kelly and Ogura, Yuji and Kiyosawa, Naoki},
title = {Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084291}
}
EUVIMED